中文
相关论文

相关论文: Bayesian data augmentation dose finding with conti…

200 篇论文

Exploratory cancer drug studies test multiple tumor cell lines against multiple candidate drugs. The goal in each paired (cell line, drug) experiment is to map out the dose-response curve of the cell line as the dose level of the drug…

机器学习 · 统计学 2021-03-23 Wesley Tansey , Christopher Tosh , David M. Blei

State-of-the-art causal discovery methods usually assume that the observational data is complete. However, the missing data problem is pervasive in many practical scenarios such as clinical trials, economics, and biology. One…

机器学习 · 计算机科学 2023-01-18 Erdun Gao , Ignavier Ng , Mingming Gong , Li Shen , Wei Huang , Tongliang Liu , Kun Zhang , Howard Bondell

Bayesian causal inference offers a principled approach to policy evaluation of proposed interventions on mediators or time-varying exposures. We outline a general approach to the estimation of causal quantities for settings with…

统计方法学 · 统计学 2019-02-28 Leah Comment , Brent A. Coull , Corwin Zigler , Linda Valeri

In parametric Bayesian designs of early phase cancer clinical trials with drug combinations exploring a discrete set of partially ordered doses, several authors claimed that there is no added value in including an interaction term to model…

统计方法学 · 统计学 2022-08-12 Mourad Tighiouart , José L. Jiménez , Marcio A. Diniz , André Rogatko

Precision medicine stands as a transformative approach in healthcare, offering tailored treatments that can enhance patient outcomes and reduce healthcare costs. As understanding of complex disease improves, clinical trials are being…

统计方法学 · 统计学 2024-05-15 Lara Maleyeff , Shirin Golchi , Erica E. M. Moodie , Marie Hudson

Two useful strategies to speed up drug development are to increase the patient accrual rate and use novel adaptive designs. Unfortunately, these two strategies often conflict when the evaluation of the outcome cannot keep pace with the…

统计方法学 · 统计学 2018-07-24 Ruitao Lin , Ying Yuan

Phase 1-2 designs provide a methodological advance over phase 1 designs for dose finding by using both clinical response and toxicity. A phase 1-2 trial still may fail to select a truly optimal dose. because early response is not a perfect…

应用统计 · 统计学 2024-04-03 Cheng-Han Yang , Peter F. Thall , Ruitao Lin

Precision medicine has led to a paradigm shift allowing the development of targeted drugs that are agnostic to the tumor location. In this context, basket trials aim to identify which tumor types - or baskets - would benefit from the…

统计方法学 · 统计学 2026-01-05 Marcio A. Diniz , Hulya Kocyigit , Erin Moshier , Madhu Mazumdar , Deukwoo Kwon

When analyzing data from randomized clinical trials, covariate adjustment can be used to account for chance imbalance in baseline covariates and to increase precision of the treatment effect estimate. A practical barrier to covariate…

统计方法学 · 统计学 2023-07-04 Chia-Rui Chang , Yue Song , Fan Li , Rui Wang

Data augmentation has been widely applied as an effective methodology to improve generalization in particular when training deep neural networks. Recently, researchers proposed a few intensive data augmentation techniques, which indeed…

机器学习 · 计算机科学 2019-11-22 Zhuoxun He , Lingxi Xie , Xin Chen , Ya Zhang , Yanfeng Wang , Qi Tian

While data augmentation (DA) is generally applied to input data, several studies have reported that applying DA to hidden layers in neural networks, i.e., feature augmentation, can improve performance. However, in previous studies, the…

机器学习 · 计算机科学 2024-08-27 Tomoumi Takase , Ryo Karakida

Random allocation models used in clinical trials aid researchers in determining which of a particular treatment provides the best results by reducing bias between groups. Often however, this determination leaves researchers battling ethical…

应用统计 · 统计学 2020-08-04 Albert. H. Lee , Edward L Boone , Roy T. Sabo , Erin Donahue

With the development of novel therapies such as molecularly targeted agents and immunotherapy, the maximum tolerated dose paradigm that "more is better" does not necessarily hold anymore. In this context, doses and schedules of novel…

统计方法学 · 统计学 2025-11-24 Anaïs Andrillon , Sandrine Micallef , Moreno Ursino , Pavel Mozgunov , Marie-Karelle Riviere

This paper proposes two methods for causal additive models with unobserved variables (CAM-UV). CAM-UV assumes that the causal functions take the form of generalized additive models and that latent confounders are present. First, we propose…

机器学习 · 计算机科学 2024-01-19 Takashi Nicholas Maeda , Shohei Shimizu

Due to the lack of available annotated medical images, accurate computer-assisted diagnosis requires intensive Data Augmentation (DA) techniques, such as geometric/intensity transformations of original images; however, those transformed…

计算机视觉与模式识别 · 计算机科学 2019-04-01 Changhee Han , Leonardo Rundo , Ryosuke Araki , Yujiro Furukawa , Giancarlo Mauri , Hideki Nakayama , Hideaki Hayashi

Dementia is a growing problem as our society ages, and detection methods are often invasive and expensive. Recent deep-learning techniques can offer a faster diagnosis and have shown promising results. However, they require large amounts of…

计算与语言 · 计算机科学 2022-07-19 Anna Hlédiková , Dominika Woszczyk , Alican Akman , Soteris Demetriou , Björn Schuller

While deep learning through empirical risk minimization (ERM) has succeeded at achieving human-level performance at a variety of complex tasks, ERM is not robust to distribution shifts or adversarial attacks. Synthetic data augmentation…

As an effective strategy, data augmentation (DA) alleviates data scarcity scenarios where deep learning techniques may fail. It is widely applied in computer vision then introduced to natural language processing and achieves improvements in…

计算与语言 · 计算机科学 2022-06-28 Bohan Li , Yutai Hou , Wanxiang Che

Researchers are often interested in predicting outcomes, conducting clustering analysis to detect distinct subgroups of their data, or computing causal treatment effects. Pathological data distributions that exhibit skewness and…

统计方法学 · 统计学 2020-08-24 Arman Oganisian , Nandita Mitra , Jason Roy

Incorporating historical data or real-world evidence has a great potential to improve the efficiency of phase I clinical trials and to accelerate drug development. For model-based designs, such as the continuous reassessment method (CRM),…

统计方法学 · 统计学 2020-06-11 Yanhong Zhou , J. Jack Lee , Shunguang Wang , Stuart Bailey , Ying Yuan